Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06679465
PHASE4

Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response

Sponsor: University of Saskatchewan

View on ClinicalTrials.gov

Summary

Evaluate single dose (2 x 2.5mcg/puff; total dose 5mcg) effect of tiotropium administered 30 minutes prior to allergen challenge on allergen-induced EAR assessed as the maximal % fall in FEV1 after allergen inhalation compared to that of single dose (two puffs) matched placebo administered 30 minutes prior to allergen challenge.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2025-01-01

Completion Date

2027-01

Last Updated

2024-11-07

Healthy Volunteers

No

Interventions

DRUG

Tiotropium (Spiriva®)

2 puffs tiotropium prior to allergen challenge

DRUG

Placebo

2 puffs placebo

Locations (1)

University of Saskatchewan

Saskatoon, Saskatchewan, Canada